Gene · 5754
Papers1,606
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,606
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| To β or Not to β: How Important Is β-Catenin Dependent and Independent WNT Signaling in CLL? | Cancers (Basel) | 2022 | 36612190 | PubTator, text mining | PubMed |
| Effects of morphology and size of nanoscale drug carriers on cellular uptake and internalization process: a review. | RSC Adv | 2022 | 36605676 | PubTator, text mining | PubMed |
| Applications of electrochemical biosensors based on 2D materials and their hybrid composites in hematological malignancies diagnosis. | Technol Cancer Res Treat | 2022 | 36567603 | PubTator, text mining | PubMed |
| Tumor Suppressor miRNA-503 Inhibits Cell Invasion in Head and Neck Cancer through the Wnt Signaling Pathway via the WNT3A/MMP Molecular Axis. | Int J Mol Sci | 2022 | 36555553 | PubTator, text mining | PubMed |
| A Genome-Wide Association Study into the Aetiology of Congenital Solitary Functioning Kidney. | Biomedicines | 2022 | 36551779 | PubTator, text mining | PubMed |
| Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling. | J Biomed Sci | 2022 | 36550569 | PubTator, text mining | PubMed |
| Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers. | Front Cell Dev Biol | 2022 | 36544906 | PubTator, text mining | PubMed |
| Insights on the Dynamic Innovative Tumor Targeted-Nanoparticles-Based Drug Delivery Systems Activation Techniques. | Int J Nanomedicine | 2022 | 36514378 | PubTator, text mining | PubMed |
| Targeted Protein Degradation: Clinical Advances in the Field of Oncology. | Int J Mol Sci | 2022 | 36499765 | PubTator, text mining | PubMed |
| Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy. | Front Oncol | 2022 | 36483047 | PubTator, text mining | PubMed |
| Comparative glycoproteomics study on the surface of SKOV3 versus IOSE80 cell lines. | Front Chem | 2022 | 36482940 | PubTator, text mining | PubMed |
| Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate. | Biomater Res | 2022 | 36471380 | PubTator, text mining | PubMed |
| Investigating the potential of a prematurely aged immune phenotype in severely injured patients as predictor of risk of sepsis. | Immun Ageing | 2022 | 36471343 | PubTator, text mining | PubMed |
| Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer. | Ann Transl Med | 2022 | 36467370 | PubTator, text mining | PubMed |
| A single N6-methyladenosine site regulates lncRNA HOTAIR function in breast cancer cells. | PLoS Biol | 2022 | 36441764 | PubTator, text mining | PubMed |
| Silver Halide-Based Nanomaterials in Biomedical Applications and Biosensing Diagnostics. | Nanoscale Res Lett | 2022 | 36437419 | PubTator, text mining | PubMed |
| Aptamer-Based Probes for Cancer Diagnostics and Treatment. | Life (Basel) | 2022 | 36431072 | PubTator, text mining | PubMed |
| Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics. | Int J Mol Sci | 2022 | 36430951 | PubTator, text mining | PubMed |
| Exhausted but Not Senescent T Lymphocytes Predominate in Lupus Nephritis Patients. | Int J Mol Sci | 2022 | 36430418 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Identifies Tumor Cell Surface Targets for CAR-T Cell Therapies and Antibody Drug Conjugates. | Cancers (Basel) | 2022 | 36428765 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5754/papers?page=16